Companies: 10,795·Total market cap: $144.5T
Biodesix, Inc.

Biodesix, Inc.

BDSXNASDAQHealthcare● Active
$15.41
+$0.46(+3.08%)
Market Cap$125441699
P/E Ratio
52W High$20.21
52W Low$5

Biodesix, Inc. (BDSX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BDSX · as of Jun 9, 2026

Activity summary

Buy transactions

9

P-Purchase only

Sell transactions

35

12 Months

Buy/Sell ratio

0.26

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 20%Active transactions only · RSU vesting excluded80% Sell ↓

Biodesix, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

BDSX insider buying and selling by quarter

BDSX insider selling · BDSX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
6.0M3.0M0
2025 Q2
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · BDSX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

BDSX executive sell shares · BDSX board member insider trading · BDSX insider trading SEC filing

Showing 54 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

PATIENCE JOHN

Director

Option

Date

Mar 31

Shares

1,361

Price

Value

View Form 4 on SEC.gov

Pestano Gary Anthony

Chief Development Officer

Option

Date

Feb 20

Shares

1,528

Price

Value

View Form 4 on SEC.gov

Pestano Gary Anthony

Chief Development Officer

Sale

Date

Feb 23

Shares

556

Price

$12.78

Value

$7K

View Form 4 on SEC.gov

O'Kane Kieran

Chief Commercial Officer

Option

Date

Feb 20

Shares

1,469

Price

Value

View Form 4 on SEC.gov

O'Kane Kieran

Chief Commercial Officer

Sale

Date

Feb 23

Shares

535

Price

$12.78

Value

$7K

View Form 4 on SEC.gov

Cowie Robin Harper

CFO, Sec'y & Treasurer

Option

Date

Feb 20

Shares

1,469

Price

Value

View Form 4 on SEC.gov

Cowie Robin Harper

CFO, Sec'y & Treasurer

Sale

Date

Feb 23

Shares

535

Price

$12.78

Value

$7K

View Form 4 on SEC.gov

Vazquez Chris

CAO

Option

Date

Feb 20

Shares

563

Price

Value

View Form 4 on SEC.gov

Vazquez Chris

CAO

Sale

Date

Feb 23

Shares

211

Price

$12.78

Value

$3K

View Form 4 on SEC.gov

Hutton Scott

President & CEO · Director

Option

Date

Feb 20

Shares

4,844

Price

Value

View Form 4 on SEC.gov

Hutton Scott

President & CEO · Director

Sale

Date

Feb 23

Shares

1,490

Price

$12.78

Value

$19K

View Form 4 on SEC.gov

O'Kane Kieran

Chief Commercial Officer

Option

Date

Feb 9

Shares

1,600

Price

Value

View Form 4 on SEC.gov

O'Kane Kieran

Chief Commercial Officer

Sale

Date

Feb 10

Shares

584

Price

$10.08

Value

$6K

View Form 4 on SEC.gov

Vazquez Chris

CAO

Option

Date

Feb 9

Shares

263

Price

Value

View Form 4 on SEC.gov

Vazquez Chris

CAO

Sale

Date

Feb 10

Shares

101

Price

$10.08

Value

$1K

View Form 4 on SEC.gov

Hutton Scott

President & CEO · Director

Option

Date

Feb 9

Shares

9,998

Price

Value

View Form 4 on SEC.gov

Hutton Scott

President & CEO · Director

Sale

Date

Feb 10

Shares

3,559

Price

$10.08

Value

$36K

View Form 4 on SEC.gov

Cowie Robin Harper

CFO, Sec'y & Treasurer

Option

Date

Feb 9

Shares

2,584

Price

Value

View Form 4 on SEC.gov

Cowie Robin Harper

CFO, Sec'y & Treasurer

Sale

Date

Feb 10

Shares

941

Price

$10.08

Value

$9K

View Form 4 on SEC.gov

Pestano Gary Anthony

Chief Development Officer

Option

Date

Feb 9

Shares

1,481

Price

Value

View Form 4 on SEC.gov

Pestano Gary Anthony

Chief Development Officer

Sale

Date

Feb 10

Shares

540

Price

$10.08

Value

$5K

View Form 4 on SEC.gov

SCHULER JACK W

Director

Purchase

Date

Jan 26

Shares

20,000

Price

$11.80

Value

$236K

View Form 4 on SEC.gov

SCHULER JACK W

Director

Purchase

Date

Jan 23

Shares

80,000

Price

$11.81

Value

$945K

View Form 4 on SEC.gov

SCHULER JACK W

Director

Purchase

Date

Jan 22

Shares

82,465

Price

$10.96

Value

$904K

View Form 4 on SEC.gov

Vazquez Chris

CAO

Option

Date

Jan 15

Shares

219

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BDSX insider trading

BDSX insider trades

Biodesix, Inc. (BDSX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Cowie Robin Harper (CFO, Sec'y & Treasurer), Hutton Scott (President & CEO · Director), Pestano Gary Anthony (Chief Development Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. BDSX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Biodesix, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

BDSX insider trading · 5 questions

The insiders of Biodesix, Inc. (BDSX) include executives and directors such as Cowie Robin Harper (CFO, Sec'y & Treasurer), Hutton Scott (President & CEO · Director), Pestano Gary Anthony (Chief Development Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BDSX board member insider tradingwho are BDSX insidersBDSX insider rosterBiodesix, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026